Saturday, August 15, 2020 4:21:44 PM
Amidst the COVID-19 crisis and testing backlog exists a highly helpful technology to aid in solving preventable COVID-19 testing bottlenecks, cost effectively and conveniently increasing test result efficiency.
A 10.5 second COVID-19 detection test, named “GenViro Swift” that can detect the virus in Saliva or Blood.
The Genviro Swift is designed and offered by “Decision Diagnostics / Pharma Tech Solutions.” Here is the website: https://pharmatechsolutions.co/genviro.html
Once implemented the Genviro Swift returns results, in 10.5 seconds through ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY, that is also recognized as as a sensitive and effective means of virus detection by the Department of Health and Human Services as also described in the following website:
https://stacks.cdc.gov/view/cdc/79494/cdc_79494_DS1.pdf
Please contact: Decision Diagnostics Chief Executive Officer, “Keith Berman” at:
Phone: 805.446.1973
Fax: 805.446.1983
Email: info@pharmatechsolutions.co
Or please contact Decision Diagnostics Public Relations, Mr. Shep Doniger at:
Shep Doniger at 561-637-5750 or sdoniger@bdcginc.com
Thank you,
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM